# FDA Inspection 893021 - NW Cryobank - August 27, 2014

Source: https://www.keypedia.com/records/fda_inspections/nw-cryobank/8090fc8d-c110-443e-b959-04ea5f4fff26
Source feed: FDA_Inspections

> FDA Inspection 893021 for NW Cryobank on August 27, 2014. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 893021
- Company Name: NW Cryobank
- Inspection Date: 2014-08-27
- Classification: No Action Indicated (NAI)
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1098180 - 2019-06-27](https://www.keypedia.com/records/fda_inspections/nw-cryobank/0ed08021-8e95-412a-98f4-9ca4404ab3c6)
- [FDA Inspection 983345 - 2016-09-12](https://www.keypedia.com/records/fda_inspections/nw-cryobank/01f98481-eac7-4ed1-afeb-29cf1c48baed)
- [FDA Inspection 983345 - 2016-09-12](https://www.keypedia.com/records/fda_inspections/nw-cryobank/b77466a7-3884-46e8-b615-f6b9812b1f39)
- [FDA Inspection 816634 - 2013-01-29](https://www.keypedia.com/records/fda_inspections/nw-cryobank/868a8640-1c83-46bf-b58b-50a6b94352d9)

Company: https://www.keypedia.com/companies/nw-cryobank/52db108f-036d-4b7f-bc58-14d7ddc1bb2f

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d